\-\ Texto\\:\\ \ \(0\)\
\-\ afebrile\\,\\ vss\\.\ \(0\)\
\-\ \\(\\+\\)\\ left\\ cheek\\/neck\\ swelling\\.\ \(1\)\
\-\ exam\\ otherwise\\ benign\\.\ \(0\)\
\-\ observation\\ and\\ routine\\ follow\\-up\\ in\\ pediatric\\ and\\ ent\\ clinics\\.\\ hemangioma\\ is\\ a\\ clinical\\ diagnosis\\ given\\ the\\ appropriate\\ age\\ group\\ and\\ presentation\\.\\ \\ imaging\\ is\\ used\\ primarily\\ to\\ rule\\ out\\ other\\ rare\\ causes\\ \\(e\\.g\\.\\ other\\ types\\ of\\ tumors\\,\\ vascular\\ malformations\\)\\.\ \(0\)\
\-\ multiplanar\\,\\ bilateral\\ gray\\ scale\\ and\\ limited\\ doppler\\ ultrasound\\ of\\ the\\ neck\\ reveals\\ a\\ 3\\.1\\ x\\ 2\\.3\\ cm\\ heterogeneous\\,\\ hypervascular\\,\\ predominantly\\ isoechoic\\ mass\\ in\\ the\\ left\\ parotid\\ gland\\.\\ \\ subsequent\\ magnetic\\ resonance\\ imaging\\ with\\ and\\ without\\ contrast\\ demonstrates\\ a\\ lobular\\ mass\\ centered\\ in\\ left\\ parotid\\ gland\\,\\ with\\ extension\\ into\\ the\\ left\\ infratemporal\\ fossa\\ and\\ parapharyngeal\\ space\\ along\\ the\\ lateral\\ border\\ of\\ the\\ left\\ internal\\ jugular\\ vein\\.\\ there\\ is\\ additional\\ insinuation\\ of\\ the\\ mass\\ between\\ the\\ left\\ sternocleidomastoid\\ muscle\\ and\\ levator\\ scapularis\\ muscle\\.\\ \\ contrast\\ enhancement\\ is\\ intense\\ and\\ homogeneous\\,\\ and\\ there\\ are\\ numerous\\ prominent\\ flow\\ voids\\ within\\ this\\ mass\\.\ \(0\)\
\-\ infantile\\ hemangioma\\,\\ parotid\ \(0\)\
\-\ \\(1\\)\\ infantile\\ hemangioma\\ is\\ the\\ most\\ common\\ infant\\ tumor\\ and\\ most\\ common\\ pediatric\\ tumor\\ of\\ the\\ parotid\\ gland\\.\\ \ \(0\)\
\-\ \\(2\\)\\ malignant\\ tumors\\ \\(rhabdomyosarcoma\\,\\ metastatic\\ tumors\\,\\ teratoma\\,\\ primary\\ parotid\\ cancer\\,\\ and\\ lymphoproliferative\\ disease\\)\\,\\ which\\ account\\ for\\ 20\\%\\ of\\ parotid\\ neoplasms\\,\\ should\\ be\\ ruled\\ out\\ if\\ necessary\\,\\ especially\\ in\\ older\\ children\\.\\ \\(3\\)\\ benign\\ tumors\\ \\(warthin\\ tumor\\,\\ adenomas\\,\\ cystic\\ hygroma\\/lymphangioma\\,\\ lipoblastoma\\,\\ etc\\.\\)\\ account\\ for\\ 80\\%\\ of\\ parotid\\ neoplasms\\.\\ \ \(0\)\
\-\ \\(4\\)\\ inflammatory\\ or\\ infectious\\ causes\\ \\(cervical\\ adenitis\\,\\ abscess\\,\\ tuberculosis\\,\\ and\\ sarcoidosis\\)\\ are\\ unlikely\\ in\\ a\\ healthy\\ two\\ month\\ old\\ infant\\.\\ \ \(0\)\
\-\ \\(5\\)\\ miscellaneous\\ rare\\ causes\\ \\(developmental\\ cysts\\ or\\ fistulas\\,\\ congenital\\ fibromatosis\\ of\\ sternocleidomastoid\\,\\ fibrodysplasia\\ ossificans\\ progressiva\\)\\ are\\ at\\ the\\ bottom\\ of\\ the\\ differential\\.\ \(0\)\
\-\ the\\ patient\\ is\\ a\\ healthy\\ 2\\ month\\ old\\ baby\\ girl\\ with\\ a\\ rapidly\\ enlarging\\ neck\\ mass\\.\\ \\ the\\ mass\\ was\\ not\\ noted\\ on\\ initial\\ newborn\\ exam\\ at\\ birth\\.\\ \\ she\\ was\\ an\\ appropriate\\ for\\ gestational\\ age\\ baby\\ delivered\\ via\\ cesarean\\ section\\ at\\ 37\\ weeks\\ after\\ failure\\ to\\ progress\\ with\\ induction\\,\\ in\\ a\\ mother\\ with\\ preeclampsia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parotid\\:\\ 0\\.10892647875103621\ \(0\)\
\-\ tumors\\:\\ 0\\.03432851719433691\ \(0\)\
\-\ sternocleidomastoid\\:\\ 0\\.03266025787627961\ \(0\)\
\-\ hemangioma\\:\\ 0\\.03062812419948436\ \(0\)\
\-\ infantile\\:\\ 0\\.029718833614679228\ \(0\)\
\-\ gland\\:\\ 0\\.02919279698978077\ \(0\)\
\-\ causes\\:\\ 0\\.02668380238884876\ \(0\)\
\-\ account\\:\\ 0\\.025810344264183015\ \(0\)\
\-\ cheek\\/neck\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ insinuation\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ scapularis\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ hygroma\\/lymphangioma\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ lipoblastoma\\:\\ 0\\.02357090487691577\ \(0\)\
\-\ neoplasms\\:\\ 0\\.023259948156748204\ \(0\)\
\-\ baby\\:\\ 0\\.022254321250315373\ \(0\)\
\-\ pediatric\\:\\ 0\\.02200555111323038\ \(0\)\
\-\ fibrodysplasia\\:\\ 0\\.021717570169536238\ \(0\)\
\-\ infant\\:\\ 0\\.02163012727005793\ \(0\)\
\-\ appropriate\\:\\ 0\\.02154024963200242\ \(0\)\
\-\ \\(\\:\\ 0\\.021245933124819427\ \(0\)\
\-\ \\)\\:\\ 0\\.020986402709214855\ \(0\)\
\-\ progressiva\\:\\ 0\\.02063343886443419\ \(0\)\
\-\ preeclampsia\\:\\ 0\\.02063343886443419\ \(0\)\
\-\ healthy\\:\\ 0\\.020602533656184977\ \(0\)\
\-\ lymphoproliferative\\:\\ 0\\.019267594950621383\ \(0\)\
\-\ miscellaneous\\:\\ 0\\.019267594950621383\ \(0\)\
\-\ mass\\:\\ 0\\.019066219362795154\ \(0\)\
\-\ infratemporal\\:\\ 0\\.01878010415705466\ \(0\)\
\-\ warthin\\:\\ 0\\.01878010415705466\ \(0\)\
\-\ levator\\:\\ 0\\.018367936563933648\ \(0\)\
\-\ \\,\\:\\ 0\\.018095592614791937\ \(0\)\
\-\ induction\\:\\ 0\\.01801090075477717\ \(0\)\
\-\ rare\\:\\ 0\\.017745188228199444\ \(0\)\
\-\ clinics\\:\\ 0\\.016712751514719147\ \(0\)\
\-\ parapharyngeal\\:\\ 0\\.016712751514719147\ \(0\)\
\-\ cesarean\\:\\ 0\\.016712751514719147\ \(0\)\
\-\ 2\\.3\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ isoechoic\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ fibromatosis\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ bottom\\:\\ 0\\.016514601856554116\ \(0\)\
\-\ muscle\\:\\ 0\\.016413450446130184\ \(0\)\
\-\ tumor\\:\\ 0\\.015980473007573354\ \(0\)\
\-\ adenitis\\:\\ 0\\.015842638144573085\ \(0\)\
\-\ benign\\:\\ 0\\.015770322818359366\ \(0\)\
\-\ fistulas\\:\\ 0\\.015698073381818337\ \(0\)\
\-\ 3\\.1\\:\\ 0\\.015430470551452071\ \(0\)\
\-\ left\\:\\ 0\\.015338587207586869\ \(0\)\
\-\ ossificans\\:\\ 0\\.015306085482909577\ \(0\)\
\-\ adenomas\\:\\ 0\\.015187230502773659\ \(0\)\
\-\ out\\:\\ 0\\.015101892389617733\ \(0\)\
\-\ vss\\:\\ 0\\.014964285024326998\ \(0\)\
\-\ multiplanar\\:\\ 0\\.014758506839471039\ \(0\)\
\-\ delivered\\:\\ 0\\.014567440090855678\ \(0\)\
\-\ age\\:\\ 0\\.013908611366547093\ \(0\)\
\-\ month\\:\\ 0\\.013709168667382938\ \(0\)\
\-\ ent\\:\\ 0\\.013707590828482785\ \(0\)\
\-\ hypervascular\\:\\ 0\\.013514220075596084\ \(0\)\
\-\ neck\\:\\ 0\\.01341841249742504\ \(0\)\
\-\ resonance\\:\\ 0\\.01339266292565823\ \(0\)\
\-\ centered\\:\\ 0\\.01339266292565823\ \(0\)\
\-\ magnetic\\:\\ 0\\.013110950316947464\ \(0\)\
\-\ jugular\\:\\ 0\\.013110950316947464\ \(0\)\
\-\ scale\\:\\ 0\\.013058002115620781\ \(0\)\
\-\ voids\\:\\ 0\\.013058002115620781\ \(0\)\
\-\ lobular\\:\\ 0\\.012905172132091507\ \(0\)\
\-\ progress\\:\\ 0\\.012905172132091507\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.012856110263994724\ \(0\)\
\-\ malformations\\:\\ 0\\.01276060736933676\ \(0\)\
\-\ ruled\\:\\ 0\\.012714105383476147\ \(0\)\
\-\ rapidly\\:\\ 0\\.012668398342408498\ \(0\)\
\-\ newborn\\:\\ 0\\.012450896632638571\ \(0\)\
\-\ etc\\:\\ 0\\.012368619470428\ \(0\)\
\-\ section\\:\\ 0\\.012249764490292081\ \(0\)\
\-\ gestational\\:\\ 0\\.012173365098730436\ \(0\)\
\-\ e\\.g\\:\\ 0\\.012099088189353227\ \(0\)\
\-\ intense\\:\\ 0\\.012099088189353227\ \(0\)\
\-\ primarily\\:\\ 0\\.01199140396705927\ \(0\)\
\-\ common\\:\\ 0\\.011958648192280198\ \(0\)\
\-\ group\\:\\ 0\\.011887889228608227\ \(0\)\
\-\ \\+\\:\\ 0\\.011788233092786751\ \(0\)\
\-\ observation\\:\\ 0\\.011723801136693005\ \(0\)\
\-\ types\\:\\ 0\\.01166088536821655\ \(0\)\
\-\ enlarging\\:\\ 0\\.011629974078374102\ \(0\)\
\-\ older\\:\\ 0\\.011509783201737027\ \(0\)\
\-\ 37\\:\\ 0\\.011480561088014592\ \(0\)\
\-\ gray\\:\\ 0\\.011178581378975568\ \(0\)\
\-\ doppler\\:\\ 0\\.011051837424711974\ \(0\)\
\-\ birth\\:\\ 0\\.010978578135438942\ \(0\)\
\-\ border\\:\\ 0\\.010883920576479272\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.010883920576479272\ \(0\)\
\-\ unlikely\\:\\ 0\\.010883920576479272\ \(0\)\
\-\ homogeneous\\:\\ 0\\.010815063635028965\ \(0\)\
\-\ 80\\:\\ 0\\.01074793550366245\ \(0\)\
\-\ imaging\\:\\ 0\\.010706277136126216\ \(0\)\
\-\ predominantly\\:\\ 0\\.010704101787684706\ \(0\)\
\-\ teratoma\\:\\ 0\\.010682451492945083\ \(0\)\
\-\ \\%\\:\\ 0\\.010659470766556189\ \(0\)\
\-\ developmental\\:\\ 0\\.010618532987989055\ \(0\)\
\-\ afebrile\\:\\ 0\\.010556106881045229\ \(0\)\
\-\ most\\:\\ 0\\.010549920544000406\ \(0\)\
\-\ other\\:\\ 0\\.010532826463649458\ \(0\)\
\-\ mother\\:\\ 0\\.01043546400596376\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.010320030391350902\ \(0\)\
\-\ numerous\\:\\ 0\\.010245753481973695\ \(0\)\
\-\ contrast\\:\\ 0\\.010228746988277568\ \(0\)\
\-\ necessary\\:\\ 0\\.010120536103139205\ \(0\)\
\-\ exam\\:\\ 0\\.010038684170853145\ \(0\)\
\-\ children\\:\\ 0\\.009870466429313473\ \(0\)\
\-\ 2\\:\\ 0\\.0098401309973826\ \(0\)\
\-\ infectious\\:\\ 0\\.009823141356855181\ \(0\)\
\-\ via\\:\\ 0\\.009807550660837019\ \(0\)\
\-\ limited\\:\\ 0\\.009641797516377212\ \(0\)\
\-\ rule\\:\\ 0\\.009541428748144417\ \(0\)\
\-\ especially\\:\\ 0\\.0094042809021884\ \(0\)\
\-\ prominent\\:\\ 0\\.009377675739479393\ \(0\)\
\-\ are\\:\\ 0\\.009343908068419267\ \(0\)\
\-\ fossa\\:\\ 0\\.009312298477810505\ \(0\)\
\-\ at\\:\\ 0\\.00928687020987941\ \(0\)\
\-\ routine\\:\\ 0\\.00916162217687165\ \(0\)\
\-\ additional\\:\\ 0\\.00916162217687165\ \(0\)\
\-\ is\\:\\ 0\\.009020707674621268\ \(0\)\
\-\ cysts\\:\\ 0\\.008950423216126649\ \(0\)\
\-\ failure\\:\\ 0\\.008950423216126649\ \(0\)\
\-\ reveals\\:\\ 0\\.008939165107740704\ \(0\)\
\-\ subsequent\\:\\ 0\\.008894600796282919\ \(0\)\
\-\ used\\:\\ 0\\.008765198280609524\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.008401591328328892\ \(0\)\
\-\ congenital\\:\\ 0\\.008356040025781919\ \(0\)\
\-\ cervical\\:\\ 0\\.008302383440084568\ \(0\)\
\-\ vein\\:\\ 0\\.008267201395759672\ \(0\)\
\-\ malignant\\:\\ 0\\.008258477744329681\ \(0\)\
\-\ 20\\:\\ 0\\.008215281380098973\ \(0\)\
\-\ otherwise\\:\\ 0\\.008206725223065092\ \(0\)\
\-\ extension\\:\\ 0\\.00815595540422902\ \(0\)\
\-\ girl\\:\\ 0\\.00803309473526684\ \(0\)\
\-\ inflammatory\\:\\ 0\\.007923304663615037\ \(0\)\
\-\ presentation\\:\\ 0\\.007870055172436049\ \(0\)\
\-\ given\\:\\ 0\\.007832658803519632\ \(0\)\
\-\ internal\\:\\ 0\\.0076600959127774634\ \(0\)\
\-\ swelling\\:\\ 0\\.007611793753960247\ \(0\)\
\-\ initial\\:\\ 0\\.007571075249409914\ \(0\)\
\-\ space\\:\\ 0\\.007557639056354638\ \(0\)\
\-\ along\\:\\ 0\\.007550946194808866\ \(0\)\
\-\ flow\\:\\ 0\\.007550946194808866\ \(0\)\
\-\ x\\:\\ 0\\.007537610522319457\ \(0\)\
\-\ cancer\\:\\ 0\\.007511137070494025\ \(0\)\
\-\ vascular\\:\\ 0\\.007491452588031274\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.007433253987812144\ \(0\)\
\-\ a\\:\\ 0\\.0074229909431289005\ \(0\)\
\-\ should\\:\\ 0\\.007283980058526203\ \(0\)\
\-\ differential\\:\\ 0\\.007253903287039918\ \(0\)\
\-\ between\\:\\ 0\\.007241966674396374\ \(0\)\
\-\ abscess\\:\\ 0\\.007224161080572907\ \(0\)\
\-\ clinical\\:\\ 0\\.007030240107128353\ \(0\)\
\-\ there\\:\\ 0\\.006800617949010634\ \(0\)\
\-\ ultrasound\\:\\ 0\\.006778402633706693\ \(0\)\
\-\ primary\\:\\ 0\\.006768407120041968\ \(0\)\
\-\ in\\:\\ 0\\.0067603833712340375\ \(0\)\
\-\ 5\\:\\ 0\\.006684920915626105\ \(0\)\
\-\ cystic\\:\\ 0\\.006589927024737321\ \(0\)\
\-\ two\\:\\ 0\\.006543666410737983\ \(0\)\
\-\ weeks\\:\\ 0\\.006484699884762428\ \(0\)\
\-\ she\\:\\ 0\\.006413866688380139\ \(0\)\
\-\ 4\\:\\ 0\\.006366235040585682\ \(0\)\
\-\ if\\:\\ 0\\.006199848753424158\ \(0\)\
\-\ cm\\:\\ 0\\.006128224913949159\ \(0\)\
\-\ enhancement\\:\\ 0\\.006124301513697957\ \(0\)\
\-\ for\\:\\ 0\\.005848461085369373\ \(0\)\
\-\ and\\:\\ 0\\.005775690023493641\ \(0\)\
\-\ metastatic\\:\\ 0\\.005751629421433396\ \(0\)\
\-\ bilateral\\:\\ 0\\.005544967190680331\ \(0\)\
\-\ into\\:\\ 0\\.005436701518608842\ \(0\)\
\-\ 1\\:\\ 0\\.005436701518608842\ \(0\)\
\-\ noted\\:\\ 0\\.005415564675006934\ \(0\)\
\-\ without\\:\\ 0\\.00537971434855123\ \(0\)\
\-\ or\\:\\ 0\\.005355736625474372\ \(0\)\
\-\ 3\\:\\ 0\\.005350201943065614\ \(0\)\
\-\ was\\:\\ 0\\.005284906535902068\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005246575750749785\ \(0\)\
\-\ the\\:\\ 0\\.005175106914039468\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0049909657798213524\ \(0\)\
\-\ lateral\\:\\ 0\\.0049376150952528085\ \(0\)\
\-\ after\\:\\ 0\\.004727275942805354\ \(0\)\
\-\ old\\:\\ 0\\.004678794635627029\ \(0\)\
\-\ within\\:\\ 0\\.00435864012937455\ \(0\)\
\-\ which\\:\\ 0\\.004265092479258151\ \(0\)\
\-\ disease\\:\\ 0\\.003734592356191722\ \(0\)\
\-\ be\\:\\ 0\\.003523413698780559\ \(0\)\
\-\ not\\:\\ 0\\.003301654202518544\ \(0\)\
\-\ an\\:\\ 0\\.0031595317226864434\ \(0\)\
\-\ of\\:\\ 0\\.0028035673988820744\ \(0\)\
\-\ this\\:\\ 0\\.0025698855970966122\ \(0\)\
\-\ patient\\:\\ 0\\.00229035275646093\ \(0\)\
\-\ to\\:\\ 0\\.002283786676165702\ \(0\)\
\-\ on\\:\\ 0\\.001935537466217722\ \(0\)\
\-\ \\.\\:\\ 0\\.0018983709142965921\ \(0\)\
\-\ with\\:\\ 0\\.001564226953073392\ \(0\)\
